Spero Therapeutics Inc (NASDAQ:SPRO)

13.16
Delayed Data
As of 4:00pm ET
 +0.07 / +0.53%
Today’s Change
9.66
Today|||52-Week Range
19.00
+12.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2017
Quarter 4
2017

--

--
Revenue and IncomeNet Revenues597.0K993.0K----
 
 
 
Depreciation And Amortization94.0K99.0K----
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.5M14.9M----
 
 
 
Research And Development6.9M12.5M----
 
 
 
Total Operating Expenses10.6M15.0M----
 
 
 
 
Non-Operating ExpensesOperating Income-10.0M-14.0M----
 
 
 
Extraordinary Charge-2.0K-6.0K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.8M-13.9M----
 
 
 
Minority Interest-8.0K-6.0K----
 
 
 
Preferred Dividend-2.2M-908.0K----
 
 
 
Net Income-9.8M-13.9M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS335.3K9.3M----
 
 
 
Shares To Calculate EPS Diluted335.3K9.3M----
 
 
 
 
Earnings Per ShareEPS-$36.02-$1.59----
 
 
 
EPS Diluted-$36.02-$1.59----